Literature DB >> 11067859

Therapeutic applications of transcription factor decoy oligonucleotides.

M J Mann1, V J Dzau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067859      PMCID: PMC301425          DOI: 10.1172/JCI11459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  41 in total

1.  Selection and characterization of an RNA decoy for transcription factor NF-kappa B.

Authors:  L L Lebruska; L J Maher
Journal:  Biochemistry       Date:  1999-03-09       Impact factor: 3.162

2.  Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6.

Authors:  S Gaubatz; J G Wood; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2.

Authors:  D Bishop-Bailey; T Hla
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.

Authors:  M J Mann; G H Gibbons; H Hutchinson; R S Poston; E G Hoyt; R C Robbins; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.

Authors:  M J Mann; A D Whittemore; M C Donaldson; M Belkin; M S Conte; J F Polak; E J Orav; A Ehsan; G Dell'Acqua; V J Dzau
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

6.  Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.

Authors:  I Kawamura; R Morishita; N Tomita; E Lacey; M Aketa; S Tsujimoto; T Manda; M Tomoi; I Kida; J Higaki; Y Kaneda; K Shimomura; T Ogihara
Journal:  Gene Ther       Date:  1999-01       Impact factor: 5.250

7.  Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo.

Authors:  S Tomita; N Tomita; T Yamada; L Zhang; Y Kaneda; R Morishita; T Ogihara; V J Dzau; M Horiuchi
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

8.  A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer.

Authors:  H E von der Leyen; R Braun-Dullaeus; M J Mann; L Zhang; J Niebauer; V J Dzau
Journal:  Hum Gene Ther       Date:  1999-09-20       Impact factor: 5.695

9.  Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.

Authors:  R S Poston; M J Mann; E G Hoyt; M Ennen; V J Dzau; R C Robbins
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

10.  Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells.

Authors:  N Tomita; R Morishita; S Tomita; K Yamamoto; M Aoki; H Matsushita; S Hayashi; J Higaki; T Ogihara
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

View more
  55 in total

1.  Developing aptamers into therapeutics.

Authors:  R R White; B A Sullenger; C P Rusconi
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.

Authors:  Philippe de Diesbach; Francisca N'Kuli; Catherine Berens; Etienne Sonveaux; Michel Monsigny; Annie-Claude Roche; Pierre J Courtoy
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

3.  Protein-DNA footprinting by endcapped duplex oligodeoxyribonucleotides.

Authors:  Pei-Sze Ng; Donald E Bergstrom
Journal:  Nucleic Acids Res       Date:  2004-07-19       Impact factor: 16.971

4.  Programmable gene regulation for metabolic engineering using decoy transcription factor binding sites.

Authors:  Tiebin Wang; Nathan Tague; Stephen A Whelan; Mary J Dunlop
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

5.  Hemodynamically driven vein graft remodeling: a systems biology approach.

Authors:  Scott A Berceli; Roger Tran-Son-Tay; Marc Garbey; Zhihua Jiang
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

6.  Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.

Authors:  Chun-Xiao Yu; Tong Jin; Wei-Wen Chen; Peng-Ju Zhang; Wen-Wen Liu; Heng-Yun Guan; Ju Zhang; Qing-Wei Liu; An-Li Jiang
Journal:  Mol Biol Rep       Date:  2009-03-05       Impact factor: 2.316

7.  NF-kappaB decoy oligonucleotides suppress RANTES expression and monocyte chemotactic activity via NF-kappaB inactivation in stromal cells of ectopic endometrium.

Authors:  Wang Xiu-li; Han Su-ping; Dai Hui-hua; You Zhi-xue; Fu Shi-long; Lu Pin-hong
Journal:  J Clin Immunol       Date:  2009-01-27       Impact factor: 8.317

Review 8.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

Review 9.  Neointimal hyperplasia associated with synthetic hemodialysis grafts.

Authors:  Li Li; Christi M Terry; Yan-Ting E Shiu; Alfred K Cheung
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

10.  Identification of a novel type 1 diabetes susceptibility gene, T-bet.

Authors:  Yuka Sasaki; Kenji Ihara; Nobuo Matsuura; Hitoshi Kohno; Seiho Nagafuchi; Ryuichi Kuromaru; Koichi Kusuhara; Ryu Takeya; Timothy Hoey; Hideki Sumimoto; Toshiro Hara
Journal:  Hum Genet       Date:  2004-07-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.